|
General Information
|
|
|
Product
|
Cytokeratin 7 Peptide
|
|
Description
|
Antigenic Blocking Peptide keratin, type II cytoskeletal 7 Antibody Mid Region
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 101-151 on human keratin, type II cytoskeletal 7 protein.
|
|
Accession #
|
NCBI: NP_005547
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
Mid Region
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P08729.5
|
|
Overview
|
Serves to block interferon-dependent interphase and stimulates DNA synthesis. Plays a role in the translational regulation of human papillomavirus type 16 E7 mRNA.
|
|
Molecular Function
|
Structural molelcule activity; Host-virus interaction
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Expressed in cultured epidermal, bronchial and mesothelial cells. Seen throughout the glandular cells at the junction of the stomac and esophagus; not present in the esophogus, colon, ectocervix and liver.
|
|
Structure
|
Heterotetramer of two type I and two type II keratins, interacts with eukaryotic translation initiator factor 3 subunit EIF3S10 , HPV16 E7, and GPER1.
|
|
Alternative Nomenclature
|
CK 7 antibody
Cytokeratin 7 antibody
K2C7 antibody
K7 antibody
Keratin 55k type ii cytoskeletal antibody
Keratin 7 antibody
KRT 7 antibody
Krt2-7 antibody
Sarcolectin antibody
SCL antibody
Type-II keratin Kb7 antibody
|
| |
|
Cytokeratin 7 Antibody
Cytokeratin 7 Antibody FITC
Cytokeratin 7 Antibody BIOTIN
Cytokeratin 7 Positive Control
